[#item_full_content] “The minor cannabinoids that receive far less attention in the mainstream market are often the same compounds patients repeatedly describe as helpful.” By Sunehera Hasib The cannabis industry spends millions pushing specific products. But patients are having a very different conversation among themselves. In a recent analysis of nearly 18,000 posts and comments across major  Read More